FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313254826> ?p ?o ?g. }

• W4313254826 endingPage "210" @default.
• W4313254826 startingPage "199" @default.
• W4313254826 abstract "Carcinoma with apocrine differentiation (AC) is a subtype of breast carcinoma with apocrine features in >90% of the tumor. Molecular studies demonstrate AC has high expression of androgen receptor (AR) mRNA. Pure AC lack estrogen receptor (ER), progesterone receptor (PR), and express AR, with variable human epidermal growth factor 2 (HER2) status. Currently, in triple negative AC, no targetable therapies or specific diagnostic markers exist.α-Methylacyl CoA racemase (AMACR) expression was investigated as a marker of apocrine differentiation using a single-plex immunoperoxidase stain, and a novel AMACR/p63 dual stain in a subset of cases, across 1) benign apocrine lesions (apocrine metaplasia, adenosis) 2) apocrine DCIS (ADCIS), 3) AC/ invasive ductal carcinoma (IDC) with apocrine features, 4) non-apocrine triple negative breast cancer (TNBC) and 5) IDC, no special type. A sub-set of cases were evaluated by tissue microarray.AMACR expression was increased in both AC and ADCIS, with minimal expression in benign breast tissue, TNBC and IDC, NST cases. In invasive cases, those with positive AMACR (>5% positivity) were significantly associated with higher histologic grade (P = .006), initial N stage (chi squared 0.044), and lack of ER or PR expression (both P < .001), with no correlation with overall survival. Analysis of TCGA breast cancer datasets revealed AMACR expression was significantly higher in molecularly defined apocrine carcinomas relative to basal and luminal subtypes. Moreover, high AMACR expression predicted worse relapse-free and distant-metastasis free survival, among both ER-/PR-/Her2- and ER-/PR-/Her2+ breast cancer cohorts (log-rank P = .081 and .00011, respectively).AMACR represents a promising diagnostic and prognostic marker in apocrine breast lesions. Further study is needed to determine the biologic and clinical significance of this protein in AC." @default.
• W4313254826 created "2023-01-06" @default.
• W4313254826 creator A5002012448 @default.
• W4313254826 creator A5003292464 @default.
• W4313254826 creator A5016534135 @default.
• W4313254826 creator A5024831711 @default.
• W4313254826 creator A5025387041 @default.
• W4313254826 creator A5061937236 @default.
• W4313254826 creator A5062287369 @default.
• W4313254826 creator A5067614361 @default.
• W4313254826 creator A5080986013 @default.
• W4313254826 date "2023-02-01" @default.
• W4313254826 modified "2023-09-23" @default.
• W4313254826 title "AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers" @default.
• W4313254826 cites W1934014088 @default.
• W4313254826 cites W1994049274 @default.
• W4313254826 cites W1994465944 @default.
• W4313254826 cites W1998109141 @default.
• W4313254826 cites W2020234050 @default.
• W4313254826 cites W2022904488 @default.
• W4313254826 cites W2025855191 @default.
• W4313254826 cites W2043152591 @default.
• W4313254826 cites W2054720368 @default.
• W4313254826 cites W2055509765 @default.
• W4313254826 cites W2074521053 @default.
• W4313254826 cites W2084774843 @default.
• W4313254826 cites W2090553336 @default.
• W4313254826 cites W2095128237 @default.
• W4313254826 cites W2095907870 @default.
• W4313254826 cites W2114843025 @default.
• W4313254826 cites W2131702935 @default.
• W4313254826 cites W2134539328 @default.
• W4313254826 cites W2135028398 @default.
• W4313254826 cites W2139376910 @default.
• W4313254826 cites W2147343434 @default.
• W4313254826 cites W2152355367 @default.
• W4313254826 cites W2162371443 @default.
• W4313254826 cites W2164594843 @default.
• W4313254826 cites W2246883257 @default.
• W4313254826 cites W2325384006 @default.
• W4313254826 cites W2589411605 @default.
• W4313254826 cites W2900698027 @default.
• W4313254826 cites W2968421234 @default.
• W4313254826 cites W3048530278 @default.
• W4313254826 cites W3088246102 @default.
• W4313254826 cites W3090719330 @default.
• W4313254826 cites W3185354749 @default.
• W4313254826 cites W3186799516 @default.
• W4313254826 cites W3193789626 @default.
• W4313254826 cites W4200191922 @default.
• W4313254826 cites W4224244340 @default.
• W4313254826 cites W4297682006 @default.
• W4313254826 doi "https://doi.org/10.1016/j.clbc.2022.11.012" @default.
• W4313254826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36577560" @default.
• W4313254826 hasPublicationYear "2023" @default.
• W4313254826 type Work @default.
• W4313254826 citedByCount "0" @default.
• W4313254826 crossrefType "journal-article" @default.
• W4313254826 hasAuthorship W4313254826A5002012448 @default.
• W4313254826 hasAuthorship W4313254826A5003292464 @default.
• W4313254826 hasAuthorship W4313254826A5016534135 @default.
• W4313254826 hasAuthorship W4313254826A5024831711 @default.
• W4313254826 hasAuthorship W4313254826A5025387041 @default.
• W4313254826 hasAuthorship W4313254826A5061937236 @default.
• W4313254826 hasAuthorship W4313254826A5062287369 @default.
• W4313254826 hasAuthorship W4313254826A5067614361 @default.
• W4313254826 hasAuthorship W4313254826A5080986013 @default.
• W4313254826 hasConcept C121608353 @default.
• W4313254826 hasConcept C126322002 @default.
• W4313254826 hasConcept C142724271 @default.
• W4313254826 hasConcept C143998085 @default.
• W4313254826 hasConcept C150875184 @default.
• W4313254826 hasConcept C193270364 @default.
• W4313254826 hasConcept C204232928 @default.
• W4313254826 hasConcept C2780849966 @default.
• W4313254826 hasConcept C502942594 @default.
• W4313254826 hasConcept C530470458 @default.
• W4313254826 hasConcept C71924100 @default.
• W4313254826 hasConcept C84606932 @default.
• W4313254826 hasConcept C98717036 @default.
• W4313254826 hasConceptScore W4313254826C121608353 @default.
• W4313254826 hasConceptScore W4313254826C126322002 @default.
• W4313254826 hasConceptScore W4313254826C142724271 @default.
• W4313254826 hasConceptScore W4313254826C143998085 @default.
• W4313254826 hasConceptScore W4313254826C150875184 @default.
• W4313254826 hasConceptScore W4313254826C193270364 @default.
• W4313254826 hasConceptScore W4313254826C204232928 @default.
• W4313254826 hasConceptScore W4313254826C2780849966 @default.
• W4313254826 hasConceptScore W4313254826C502942594 @default.
• W4313254826 hasConceptScore W4313254826C530470458 @default.
• W4313254826 hasConceptScore W4313254826C71924100 @default.
• W4313254826 hasConceptScore W4313254826C84606932 @default.
• W4313254826 hasConceptScore W4313254826C98717036 @default.
• W4313254826 hasFunder F4320309755 @default.
• W4313254826 hasFunder F4320310702 @default.
• W4313254826 hasFunder F4320320300 @default.
• W4313254826 hasFunder F4320332501 @default.
• W4313254826 hasIssue "2" @default.

• next